Skip to content

Pilot Study Evaluating Neuro-Imaging Correlates of Epigenetic Finding in Prediction of Chronic Postsurgical Pain

Unknown statusNCT04681183
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

This pilot research study is being performed to learn more about pain and look at how pain changes brain chemistry and function. The research team would like to learn new information to better control chronic pain after surgery. This information collected in this research will be used to plan possible future visits. Participants in this study are being asked to participate because they are scheduled for an upcoming surgery. The research team would like to observe them before and after their surgery.

Study details

Official title
Pilot Study Evaluating Neuro-Imaging Correlates of Epigenetic Finding in Prediction of Chronic Postsurgical Pain
Sponsor
Children's Hospital Medical Center, Cincinnati
Start date
2020-12-14
Primary completion
2024-12-01
Sex
All
Age range
from 8 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Male or female aged ≥ 8 yrs of age 2. English speaking; 3. Healthy (Defined as American Society of Anesthesiologists Physical Status 1 or 2) 4. Ability to provide assent/consent/parent permission. 5. Scheduled to undergo chest surgery (thoracotomy, thoracoscopy, Nuss procedure, pectus surgery, mastectomy), spine surgery, amputation, hernia repair or hip/knee replacement. Exclusion Criteria: 1. History of chronic pain conditions including migraines 2. Use of opioids chronically or for major surgery within the 6 months prior to enrollment 3. Severe obesity (BMI\>35 kg/m2) 4. Taking no more than two concomitant medications known to induce or inhibit CYP2D6 activity, including paroxetine, fluoxetine, cimetidine, and duloxetine or other medications used to treat attention deficit hyperactivity disorder (medications containing amphetamine or methylphenidate). 5. Use of hormonal contraceptives 6. Use of medications that may alter pain sensitivity (e.g. gabapentin,/pregabalin amitryptiline/other antidepressants, clonidine). 7. Active or history of renal/liver problems or congenital cardiac disease 8. Diagnosed developmental delay 9. Pregnant or lactating females 10. Any skin condition that prevents cuff application 11. History of seizures 12. Claustrophobia 13. Metallic implants/orthodontics/braces or other MRI exclusion (MRI safety screening will be conducted prior to enrollment and prior to each MRI scan)

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04681183